These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 37961864

  • 1. Integrated Network Pharmacology and Cellular Assay to Explore the Mechanisms of Selenized Tripterine Phytosomes (Se@Tri-PTs) Alleviating Podocyte Injury in Diabetic Nephropathy.
    Zhu S, Liu Q, Chang Y, Luo C, Zhang X, Sun S.
    Curr Pharm Des; 2023; 29(38):3073-3086. PubMed ID: 37961864
    [Abstract] [Full Text] [Related]

  • 2. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis.
    He J, Cui J, Shi Y, Wang T, Xin J, Li Y, Shan X, Zhu Z, Gao Y.
    J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
    [Abstract] [Full Text] [Related]

  • 3. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y, Lin S, Qiu J, Sun W, Dong M, Xiang Y, Wang L, Du P.
    Biochem Biophys Res Commun; 2020 Jan 15; 521(3):791-798. PubMed ID: 31703838
    [Abstract] [Full Text] [Related]

  • 4. Penehyclidine hydrochloride suppresses inflammation response and reduces podocyte injury in diabetic nephropathy by targeting fibrinogen-like protein 2.
    Tan HB, Zhao Q, Chen L.
    Int Immunopharmacol; 2022 Jun 15; 107():108680. PubMed ID: 35303505
    [Abstract] [Full Text] [Related]

  • 5. Neuregulin 4 Attenuates Podocyte Injury and Proteinuria in Part by Activating AMPK/mTOR-Mediated Autophagy in Mice.
    Deng J, Yang Q, Zhu W, Zhang Y, Lin M, She J, Li J, Xiao Y, Xiao J, Xu X, He H, Zhu B, Ding Y.
    J Cell Biochem; 2024 Oct 15; 125(10):e30634. PubMed ID: 39091188
    [Abstract] [Full Text] [Related]

  • 6. [Triptolide inhibits NLRP3 inflammasome activation and ameliorates podocyte epithelial-mesenchymal transition induced by high glucose].
    Wu W, Liu BH, Wan YG, Sun W, Liu YL, Wang WW, Fang QJ, Tu Y, Yee HY, Yuan CC, Wan ZY.
    Zhongguo Zhong Yao Za Zhi; 2019 Dec 15; 44(24):5457-5464. PubMed ID: 32237395
    [Abstract] [Full Text] [Related]

  • 7. Artificially Cultivated Ophiocordyceps sinensis Alleviates Diabetic Nephropathy and Its Podocyte Injury via Inhibiting P2X7R Expression and NLRP3 Inflammasome Activation.
    Wang C, Hou XX, Rui HL, Li LJ, Zhao J, Yang M, Sun LJ, Dong HR, Cheng H, Chen YP.
    J Diabetes Res; 2018 Dec 15; 2018():1390418. PubMed ID: 30534570
    [Abstract] [Full Text] [Related]

  • 8. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y, Ma Y, Xie D, Jiang H.
    Int Immunopharmacol; 2022 Jun 15; 107():108711. PubMed ID: 35338958
    [Abstract] [Full Text] [Related]

  • 9. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C, Cheng T, Zhang B, Sun K, Lu K.
    Ren Fail; 2023 Dec 15; 45(1):2165103. PubMed ID: 36938748
    [Abstract] [Full Text] [Related]

  • 10. Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy.
    Liu Y, Liu W, Zhang Z, Hu Y, Zhang X, Sun Y, Lei Q, Sun D, Liu T, Fan Y, Li H, Ding W, Fang J.
    Ren Fail; 2021 Dec 15; 43(1):128-140. PubMed ID: 33427556
    [Abstract] [Full Text] [Related]

  • 11. Phytosomal tripterine with selenium modification attenuates the cytotoxicity and restrains the inflammatory evolution via inhibiting NLRP3 inflammasome activation and pyroptosis.
    Liu S, Chen Q, Yan L, Ren Y, Fan J, Zhang X, Zhu S.
    Int Immunopharmacol; 2022 Jul 15; 108():108871. PubMed ID: 35605435
    [Abstract] [Full Text] [Related]

  • 12. TangShenWeiNing Formula Prevents Diabetic Nephropathy by Protecting Podocytes Through the SIRT1/HIF-1α Pathway.
    Chang J, Zheng J, Gao X, Dong H, Yu H, Huang M, Sun Z, Feng X.
    Front Endocrinol (Lausanne); 2022 Jul 15; 13():888611. PubMed ID: 35721758
    [Abstract] [Full Text] [Related]

  • 13. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
    Gao J, Liang Z, Zhao F, Liu X, Ma N.
    Bioengineered; 2022 May 15; 13(5):12275-12288. PubMed ID: 35603354
    [Abstract] [Full Text] [Related]

  • 14. Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.
    Wang Y, Peng L, Lu X, Zhang H, Zhao H, Zhao T, Yang L, Mao H, Ma F, Liu T, Li P, Zhan Y.
    J Ethnopharmacol; 2024 Apr 24; 324():117721. PubMed ID: 38199335
    [Abstract] [Full Text] [Related]

  • 15. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
    Huang M, Yang Y, Chen Y, Li Y, Qin S, Xiao L, Long X, Hu K, Li Y, Ying H, Ding Y.
    J Cell Biochem; 2023 Nov 24; 124(11):1749-1763. PubMed ID: 37796169
    [Abstract] [Full Text] [Related]

  • 16. Connexin 43‑autophagy loop in the podocyte injury of diabetic nephropathy.
    Ji J, Zhao Y, Na C, Yang M, Zhu X, Shi H, Gan W, Zhang A.
    Int J Mol Med; 2019 Nov 24; 44(5):1781-1788. PubMed ID: 31545399
    [Abstract] [Full Text] [Related]

  • 17. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
    Sun L, Ding M, Chen F, Zhu D, Xie X.
    PeerJ; 2023 Nov 24; 11():e14826. PubMed ID: 36815984
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
    Liang Y, Liu H, Zhu J, Song N, Lu Z, Fang Y, Teng J, Dai Y, Ding X.
    Biochem Biophys Res Commun; 2021 Jun 25; 559():48-55. PubMed ID: 33932899
    [Abstract] [Full Text] [Related]

  • 19. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation.
    Zhang Q, Hu Y, Hu JE, Zhang M.
    Drug Dev Res; 2022 Nov 25; 83(7):1697-1706. PubMed ID: 36048966
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy.
    Su PP, Liu DW, Zhou SJ, Chen H, Wu XM, Liu ZS.
    Mil Med Res; 2022 May 26; 9(1):23. PubMed ID: 35614465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.